Given that there is no hepatic involvement in these subjects who are more likely to develop GS, this study suggests that there is no underlying liver pathology causing elevated bilirubin levels, but that it is a consequence of the UGT1A1 phenotype. The gene discussed is UGT1A1; the disease is Gerstmann syndrome.